Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20284478 | 0.83 | ALDH1A1 (0.35) | CYP1A2CYP2D6CYP2C9CYP2C19MEN1 | |
| SCHEMBL3197044 | 0.75 | PDK2 (0.33) | KDM4EMEN1MAPTKMT2A | |
| SCHEMBL15030819 | 0.74 | KDM4E (0.35) | KDM4ECYP1A2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL3209570 | 0.72 | NPC1 (0.32) | KDM4EMAPT | |
| SCHEMBL3205939 | 0.72 | PDK2 (0.34) | KDM4ECYP1A2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL10037385 | 0.72 | KDM4E (0.35) | KDM4ECYP1A2MEN1MAPTMAPK1 | |
| SCHEMBL20202064 | 0.72 | ALDH1A1 (0.44) | CYP1A2CYP2D6CYP2C9CYP2C19MEN1 | |
| SCHEMBL15030782 | 0.70 | KDM4E (0.33) | KDM4EMEN1MAPTMAPK1KMT2A | |
| SCHEMBL2754783 | 0.69 | ALDH1A1 (0.39) | KDM4ECYP1A2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL20650560 | 0.68 | KDM4E (0.31) | KDM4EMEN1MAPTMAPK1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120001537-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2012-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120001537-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME | OR10J3, ORC3, PIEZO1 | KDM4E 1720/4885CYP1A2 2391/4885CYP2D6 2826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.